Merck, Portola’s Anti-Clotting Drug Linked to Less Bleeding – BusinessWeek
Earthtimes (press release) |
Merck, Portola's Anti-Clotting Drug Linked to Less Bleeding
BusinessWeek March 15 (Bloomberg) — Merck & Co. and Portola Pharmaceuticals Inc.'s experimental anti-clotting drug betrixaban caused less bleeding than an older treatment in people with an irregular heartbeat, a study found. … Merck Drug Shown To Work Better Than Blood-Thinner Warfarin Merck blood thinner appears safe, effective Portola, Merck report postitive betrixaban results
|